Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
5,900
Employees5,900
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
5,900
Employees5,900

MEDP Key Statistics

Market cap
15.12B
Market cap15.12B
Price-Earnings ratio
40.45
Price-Earnings ratio40.45
Dividend yield
Dividend yield
Average volume
304.06K
Average volume304.06K
High today
$542.43
High today$542.43
Low today
$521.84
Low today$521.84
Open price
$521.84
Open price$521.84
Volume
279.33K
Volume279.33K
52 Week high
$547.15
52 Week high$547.15
52 Week low
$250.05
52 Week low$250.05

MEDP News

TipRanks 8h
Medpace downgraded to Underweight from Equal Weight at Barclays

Barclays downgraded Medpace (MEDP) to Underweight from Equal Weight with a price target of $425, down from $450. The downgrade is mostly on valuation, as Barcla...

Analyst ratings

57%

of 14 ratings
Buy
7.1%
Hold
57.1%
Sell
35.7%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.